Astrana Health, Inc. (ASTH)
NASDAQ: ASTH · Real-Time Price · USD
57.16
+1.68 (3.03%)
Sep 18, 2024, 4:00 PM EDT - Market closed
Astrana Health Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Astrana Health stock have an average target of 62, with a low estimate of 59 and a high estimate of 67. The average target predicts an increase of 8.47% from the current stock price of 57.16.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 15, 2024.
Analyst Ratings
The average analyst rating for Astrana Health stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '24 | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 2 | 2 | 2 |
| Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Buy Maintains $54 → $67 | Buy | Maintains | $54 → $67 | +17.21% | Aug 15, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $50 → $59 | Strong Buy | Maintains | $50 → $59 | +3.22% | Aug 9, 2024 |
| Stifel | Stifel | Strong Buy Maintains $48 → $60 | Strong Buy | Maintains | $48 → $60 | +4.97% | Aug 1, 2024 |
| Truist Securities | Truist Securities | Hold → Strong Buy Upgrades $44 → $50 | Hold → Strong Buy | Upgrades | $44 → $50 | -12.53% | Jul 11, 2024 |
| Stifel | Stifel | Strong Buy Maintains $45 → $48 | Strong Buy | Maintains | $45 → $48 | -16.03% | Jun 27, 2024 |
Financial Forecast
Revenue This Year
1.85B
from 1.39B
Increased by 33.70%
Revenue Next Year
2.32B
from 1.85B
Increased by 24.92%
EPS This Year
1.30
from 1.29
Increased by 0.95%
EPS Next Year
1.63
from 1.30
Increased by 25.33%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.0B | 2.7B | 3.1B | ||
| Avg | 1.9B | 2.3B | 2.8B | ||
| Low | 1.7B | 2.1B | 2.4B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 41.5% | 43.7% | 33.2% | ||
| Avg | 33.7% | 24.9% | 19.7% | ||
| Low | 26.1% | 12.7% | 4.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.60 | 1.98 | 2.42 |
| Avg | 1.30 | 1.63 | 2.08 |
| Low | 1.06 | 1.41 | 1.73 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 23.7% | 52.4% | 48.0% |
| Avg | 0.9% | 25.3% | 27.7% |
| Low | -18.0% | 8.4% | 6.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.